Adaptimmune Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
FLORENCE ANTHONY A. JR. 10 percent owner
 Ordinary Shares with a nominal value of 0.001 GBP per share 12,870,000 $0.7 $9,009,000
Purchase
SANDELL SCOTT D 10 percent owner
 Ordinary Shares with a nominal value of 0.001 GBP per share 12,870,000 $0.7 $9,009,000
Purchase
THOMPSON PETER A. director
 Ordinary Shares with a nominal value of GBP0.001 per share 518,400 $10.48 $5,432,832
Purchase
ORBIMED ADVISORS LLC director
 Ordinary Shares with a nominal value of GBP0.001 per share 518,400 $10.48 $5,432,832
Purchase
THOMPSON PETER A. director
 Ordinary Shares with a nominal value of GBP0.001 per share 1,191,600 $10.4 $12,392,640
Purchase
ORBIMED ADVISORS LLC director
 Ordinary Shares with a nominal value of GBP0.001 per share 1,191,600 $10.4 $12,392,640
Purchase
THOMPSON PETER A. director
 Ordinary Shares with a nominal value of GBP0.001 per share 2,400 $10.04 $24,096
Purchase
ORBIMED ADVISORS LLC director
 Ordinary Shares with a nominal value of GBP0.001 per share 2,400 $10.04 $24,096
Purchase
SIGAL CHARLES ELLIOTT director
 Ordinary Shares with a nominal value of GBP0.001 per share 15,000 $1.56 $23,400
Purchase
SIGAL CHARLES ELLIOTT director
 Ordinary Shares with a nominal value of GBP0.001 per share 15,000 $1.55 $23,250
Purchase
SIGAL CHARLES ELLIOTT director
 Ordinary Shares with a nominal value of GBP0.001 per share 15,000 $1.55 $23,250
Purchase
SIGAL CHARLES ELLIOTT director
 Ordinary Shares with a nominal value of GBP0.001 per share 15,000 $1.55 $23,250

Showing 200 to 212 of 212 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: